Skip to content

Semaglutide

Published: August 9, 2026Updated: August 9, 2026

Ozempic (semaglutide) is an injectable prescription medication for adults with type 2 diabetes that helps improve blood sugar control when used alongside diet and exercise. It belongs to a class of drugs called GLP-1 receptor agonists and may also help reduce the risk of cardiovascular events in people with diabetes and heart disease.

Quick summary

Ozempic is an injectable GLP-1 receptor agonist used to manage type 2 diabetes and support weight management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 9, 2026Editorial policy

Key facts at a glance

RxNorm
1991307
Generic
Ozempic
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Ozempic is primarily used to treat type 2 diabetes in adults. It helps improve glycemic control and may be prescribed alongside diet and exercise. It is also indicated to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease.

Ozempic is a GLP-1 (glucagon-like peptide-1) receptor agonist. It works by mimicking the GLP-1 hormone, which stimulates insulin secretion in response to meals, suppresses glucagon release, slows gastric emptying, and promotes feelings of fullness. These actions help lower blood sugar levels and may support weight loss.

Ozempic is administered as a once-weekly subcutaneous injection. Common side effects include nausea, vomiting, diarrhea, and constipation. It should not be used in patients with a personal or family history of medullary thyroid carcinoma or those with Multiple Endocrine Neoplasia syndrome type 2. Ozempic is not a substitute for insulin and is not indicated for type 1 diabetes or diabetic ketoacidosis.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 9, 2026. · Read our editorial policy